Loading clinical trials...
Loading clinical trials...
Subjects will undergo a placebo and allopurinol phase to better understand the effects of the reduced function BCRP Q141K variant on allopurinol pharmacokinetics and pharmacodynamics.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of California, San Francisco
Collaborators
NCT07116746 · Gout, Gouty Arthritis, and more
NCT06310967 · Hyperuricemia, Hypouricemia, Renal
NCT06859073 · Healthy Volunteers, Hyperuricemia
NCT07002762 · Hyperuricemia or Gout
NCT06966635 · Hyperuricemia or Gout, Nephrolithiasis
Open Medicine Institute
Mountain View, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions